Back to All
Group

Webinar: Global Laboratory Landscape Data and Strategy for Targeted Therapy Launches: Understanding CDx Intelligence and Trends

10 May, 2016

Will you be launching a targeted therapy in the next 24 to 48 months? This Labceutics webinar provides key insights into laboratory strategy, data and key market landscape differences when planning for a targeted therapy launch. Join an expert panel of targeted therapy and laboratory data experts to hear about the 'forgotten' but critical stakeholder in successful global targeted therapy launches - the molecular laboratory. Listen to this webinar to learn:

  • How the laboratory landscape and testing environment impacts therapy launches globally
  • Laboratory Mapping and optimal lab footprints based on a therapy, a test and target prescribers
  • The types of biomarker testing being done on a regional basis
  • Key testing measurement criteria about laboratories you need to know
  • Challenges and opportunities in developing regional lab networks to support quality testing

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.

Public Relations & Investor Relations advisers

Alma PR
71-73 Carter Lane
London
EC4V 5EQ.

Tel: +44 (0)20 3405 0205 or [email protected]


 
Caroline Forde
Robyn Fisher
 
Kieran Breheny